Why the study?
Do vascular assessments and novel biomarkers predict cardiovascular events in subjects with type 2 diabetes?
Population
936 subjects with type 2 diabetes with or without manifest cardiovascular disease, recruited at four…
Design
Cohort
Follow-up
3 years
Authors
Loading...
Differential biomarker associations by CVD history may refine T2D risk assessment; hypothesis-generating and requires prospective validation.
Do vascular assessments and novel biomarkers predict cardiovascular events in subjects with type 2 diabetes?
In patients with type 2 diabetes, cardiovascular risk is driven by inflammation and endothelial stress in those with prior CVD, but by atherosclerosis severity in those without prior CVD.
Shore et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: